NAT10 and hepatocellular carcinoma: Furthermore, the time‐dependent ROC analysis supported the prognostic value of NAT10, with 1‐, 3‐, and 5‐year AUC values of 0.823, 0.834, and 0.862, respectively, demonstrating its ability to predict long‐term clinical outcomes in HCC patients (Figure 1F).